{"title": "Potential new therapy for Crohn's, colitis identified", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "Potential new therapy for Crohn's, colitis identified"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190306143022.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190306143022.htm", "summary": "Researchers have found a compound that may treat inflammatory bowel disease without directly targeting inflammation. The compound tamps down the activity of a gene linked to blood clotting. They discovered that the gene was turned on at sites of intestinal inflammation and damage, and blocking its activity reduces IBD symptoms in mice.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "Researchers have found a compound that may treat inflammatory bowel disease without directly targeting inflammation. The compound tamps down the activity of a gene linked to blood clotting. They discovered that the gene was turned on at sites of intestinal inflammation and damage, and blocking its activity reduces IBD symptoms in mice."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2019/03/190306143022-large.jpg", "height": "200", "width": "300"}], "href": "", "published": "Wed, 06 Mar 2019 14:30:22 EST", "published_parsed": [2019, 3, 6, 19, 30, 22, 2, 65, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190306143022.htm", "guidislink": false}